Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration.
2017 ◽
Vol 35
(15_suppl)
◽
pp. LBA1-LBA1
◽
Keyword(s):
LBA1 The full, final text of this abstract will be available at abstracts.asco.org at 7:30 AM (EDT) on Sunday, June 4, 2017, and in the Annual Meeting Proceedings online supplement to the June 20, 2017, issue of the Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News.
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. CRA3503-CRA3503
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA5002-LBA5002
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA8500-LBA8500
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA4003-LBA4003
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA4001-LBA4001
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA9514-LBA9514
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4004-LBA4004
◽
Keyword(s):